Home > Drug Search >
  • company_query: Asklepion Pharmaceuticals
  •   > 
Drug Filter
Category:
chemistry (44) biology (25)
Status:
Approved (3) NDA Filing (1) BLA Filing (1) Phase Ⅲ (6) Phase Ⅱ (29) Phase Ⅰ (27) IND Filing (2)
Clinical Stage:
Pending (14) Active (38) Discontinued (13)
Bio-Type:
Gene therapy (1) Cell therapy (1) Vaccine (13) Allergen extract (1) Microbial extract (1) Recombinant cytokines (1) Other recombinant protein (1) Whole antibody (3) ADC (1)
Indication:
Acute lymphoblastic leukaemia (ALL) (1) Acute myeloid Leukemia (AML) (2) Allergic rhinitis (AR) (1) Allergic rhinoconjunctivitis (1) Alzheimer's disease (AD) (1) Asthma (3) Atherosclerosis (2) Atopic dermatitis (1) Breast cancer (4) Chronic pain (1) Community-acquired pneumonia (CAP) (2) Cushing's disease (1) Cutaneous fungal infections (1) Cutaneous T cell lymphoma (CTCL) (1) Respiratory-tract disorders (1) Duchenne muscular dystrophy (DMD) (1) Duodenal ulcer (1) Erectile dysfunction (ED) (1) Gastric cancer (1) Gastric ulcer (1) Glaucoma (1) HBV infection (1) HCV infection (3) Heart failure (1) Hepatocellular carcinoma (HCC) (1) HIV infection (2) Hyperlipidemia (1) Hypertension (1) Blepharospasm (1) Glabellar line (1) Torticollis (1) Dystonia (1) Rabies (1) Lung cancer (1) Malignant brain tumor (1) Melanoma (2) Multiple myeloma (MM) (1) Multiple sclerosis (MS) (2) Non small cell lung cancer (NSCLC) (2) Non-alcoholic fatty liver disease (NAFLD) (2) Obesity (1) Ovarian cancer (1) Pancreatic cancer (2) Parkinson's disease (PD) (1) Prader-Willi syndrome (1) Prostate cancer (3) Reflux esophagitis (1) Rheumatoid arthritis (RA) (2) Solid tumours (4) Systemic lupus erythematosus (1) Tinnitus (1) Type 2 diabetes (2) Ulcerative colitis (1) Urinary tract infections (1) Streptococcal infection (1) Head and neck cancer (1) Hodgkin lymphoma (1) Colorectal cancer (3) Nosocomial Pneumonia (NP) (1) Systemic bacterial infections (1) Methicillin-resistant staphylococcus aureus infections (1) Relapsed or refractory malignant lymphoma (1) Biliary cancer (1) Malaria (1) Renal carcinoma (1) Hematological cancer (1) B-cell malignancies (1) Glioblastoma (3) Ischemia-reperfusion injury (1) Plaque psoriasis (2) Esophageal squamous cell carcinoma (1) Bacterial infection (2) Muscle spasticity (1) Drug-induced dyskinesia (1) Cardiac reperfusion injury (1) Inflammation (1) Human papillomavirus infections (HPV) (1) Benign prostatic hyperplas-lower urinarytract symptoms (1)
Aprv. Year:
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 3 4 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top